GE Capital, the financial services division of US-listed industrial conglomerate General Electric, has agreed to pay R125 crore ($23m) for a 7.69% stake in Syngene International, a research subsidiary of India-based biotechnology company Biocon. Biocon had been preparing to float Syngene, which has annual sales of R400 crore last year, but will make an initial public offering (IPO) after GE’s investment. Kiran Mazumdar-Shaw, chairwoman of Biocon, said the deal gave Syngene a $300m valuation and added: “GE Capital’s investment in Syngene is a validation of our research services business model, which has delivered consistent value to our partners as well as other stakeholders. This [investment] takes us closer to our commitment of taking Syngene through an IPO at the most opportune time.” Allegro Corporate Finance Advisors and law firm Mundkur Law Partners helped Biocon on the deal. Syngene has 1,500 scientists working in a 1 million square foot building on research and development from companies as healthcare companies look to outsource part of their work. Separately, the UK state-backed Medical Research Council (MRC) will invest $11m to fund academic research projects finding new uses for 15 of Anglo-Swedish drugs group AstraZeneca’s shelved therapeutics. Patrick Johnston, chair of the MRC’s translational research group, said: “Thanks to the generosity of AstraZeneca, UK scientists will be able to carry out medical research that otherwise may never have been possible. “Not only will this bring benefits for patients in the form of more effective medicines and a better understanding of disease, but it has also allowed academic researchers to forge new partnerships with industry, which will give rise to future collaboration across the life sciences sector.” AstraZeneca will hold on to its existing intellectual property on the drugs, while the academic institutions involved in the new work gain the rights to any new research findings.
Sectors
- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- Deal Data
- Video
- Subscribe
- Newsletters
- Community & Events
GE outsources to Syngene
Nov 1, 2012 • Global Corporate Venturing
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.Featured Content
FUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.